In the US, Sincalide (sincalide systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Barium Meal Transit, Gallbladder Contraction and Pancreatic Secretion.
US matches:
- Sincalide
- Sincalide Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V04CC03
CAS registry number (Chemical Abstracts Service)
0025126-32-3
Chemical Formula
C49-H62-N10-O16-S3
Molecular Weight
1143
Therapeutic Category
Diagnostic agent, gall-bladder function
Chemical Name
Caerulein, 1-de(5-oxo-L-proline)-2-de-L-glutamine-5-L-methionine-
Foreign Names
- Sincalidum (Latin)
- Sincalid (German)
- Sincalide (French)
- Sincalida (Spanish)
Generic Names
- Sincalide (OS: BAN, USAN)
- CCK 8 (IS)
- SQ 19844 (IS: Squibb)
- Sincalide for Injection (PH: USP 32)
Brand Name
- Kinevac
Bracco, United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment